Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_assertion type Assertion NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_head.
- NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_assertion description "[Carriers of the APOE ?2 SNP had a significantly lower risk of CHD hazard ratio (HR) of 0.63 (95% confidence interval [CI]: 0.42-0.95), as did carriers of the APOC2 SNP rs5127 (HR = 0.72, 95% CI: 0.56-0.93), while carriers of APOC1 SNP rs4803770 had higher risk of CHD (HR = 1.36, 95% CI: 1.04-1.78) compared with noncarriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_provenance.
- NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_assertion evidence source_evidence_literature NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_provenance.
- NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_assertion SIO_000772 20498921 NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_provenance.
- NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_assertion wasDerivedFrom befree-20150227 NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_provenance.
- NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_assertion wasGeneratedBy ECO_0000203 NP244349.RA33ynvXJkNq7B1f_W2hlo27m5pwzaOcQYYL1_W1tMHD8130_provenance.